Skip to main content
Tinavi Medical Technologies Co.,Ltd. logo

Tinavi Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688277 ISIN · CNE100004256 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 760 across all filing types
Latest filing 2025-04-28 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688277

About Tinavi Medical Technologies Co.,Ltd.

https://www.tinavi.com/

Tinavi Medical Technologies Co.,Ltd. specializes in the design, development, and commercialization of orthopedic surgical robotic systems. Its primary offering, the TiRobot system, provides a multi-functional platform for spine and trauma surgeries, supporting procedures such as pedicle screw fixation and pelvic fracture reduction. The technology incorporates high-definition 3D imaging, precise mechanical arms, and advanced navigation software to facilitate minimally invasive operations with sub-millimeter accuracy. By integrating preoperative planning with real-time intraoperative guidance, the system aims to enhance surgical precision, reduce recovery times, and minimize radiation exposure for clinical teams. The company focuses on delivering intelligent robotic solutions to hospitals and specialized surgical centers to improve the consistency and safety of complex orthopedic interventions.

Recent filings

Filing Released Lang Actions
独立董事2024年度述职报告（张瑞君）
Board/Management Information Classification · 95% confidence The document is an independent director's annual performance report for the year 2024 for Beijing Tianzhihang Medical Technology Co., Ltd. It details the director's duties, attendance at board and committee meetings, opinions on various company matters including financial reports, internal controls, related party transactions, and corporate governance activities. It is a detailed narrative report on the director's activities and oversight during the year, not a financial report, earnings release, or regulatory filing. It is not a proxy statement, remuneration report, or voting results announcement. The document is a specialized governance-related report focusing on the independent director's role and activities, which fits best under Board/Management Information (MANG) as it relates to board member duties and governance oversight. The document length is sufficient and contains substantive content, not just an announcement or certification. Therefore, the classification is MANG with high confidence.
2025-04-28 Chinese
独立董事2024年度述职报告（李志勇）
Board/Management Information Classification · 95% confidence The document is a detailed annual report by an independent director of Beijing Tianzhihang Medical Technology Co., Ltd. for the year 2024. It includes comprehensive information about the director's background, attendance at board and committee meetings, oversight of company governance, review of financial reports, internal controls, related party transactions, and other governance matters. The document is not a brief announcement or a certification but a substantive report on the director's duties and observations over the year. This fits the category of Board/Management Information (MANG), which covers announcements of changes or reports related to the company's board or senior management activities. The document is 5918 characters long, which is sufficient for a detailed report rather than a short announcement. Therefore, the appropriate classification is MANG with high confidence.
2025-04-28 Chinese
2024年非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告
Audit Report / Information Classification · 95% confidence The document is a specialized audit report titled "专项审计报告" related to non-operating fund occupation and other related party fund transactions for Beijing Tianzhihang Medical Technology Co., Ltd. for the fiscal year 2024. It includes detailed audit opinions, references to Chinese auditing standards, and a summary table of related party transactions. The document is issued by a certified public accounting firm and contains substantive audit findings and financial data related to the company's fund usage and related party dealings. This is not a full annual report but a standalone audit report focusing on a specific aspect of the company's financials. Therefore, it fits the category of Audit Report / Information (AR).
2025-04-28 Chinese
2024年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告" (Audit Report) issued by a certified public accounting firm for Beijing Tianzhihang Medical Technology Co., Ltd. It contains detailed audit opinions, basis for the audit, key audit matters, management responsibilities, and auditor responsibilities. The content includes financial statements and notes, audit procedures, and conclusions on the fairness of the financial statements for the fiscal year ending December 31, 2024. The length is substantial (15,000 characters), and it is not merely an announcement or certification but the full audit report itself. Therefore, this document fits the category of an Audit Report / Information (AR).
2025-04-28 Chinese
独立董事2024年度述职报告（徐扬）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2024 Annual Work Report" for Beijing Tianzhihang Medical Technology Co., Ltd. It details the independent director's background, attendance at board and shareholder meetings, participation in committees, review of financial reports, internal control evaluations, and other governance-related activities during the 2024 fiscal year. The content focuses on the director's duties, observations, and opinions on company governance and compliance, rather than presenting financial statements or audit results. It is a detailed management-related report on the director's role and activities rather than a financial report or announcement. Therefore, this document fits best under the category of Board/Management Information (MANG), which covers announcements of changes or reports related to the company's board or senior management activities.
2025-04-28 Chinese
2024年度董事会审计委员会履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2024年度董事会审计委员会履职情况报告" which translates to the "2024 Annual Board Audit Committee Performance Report." It details the audit committee's activities, meetings, evaluations of external auditors, review of financial reports, internal audit guidance, and internal control assessments for the year 2024. The content focuses on the audit committee's oversight and evaluation of audit-related matters rather than presenting full financial statements or comprehensive annual financial performance. The document length is 1971 characters, which is relatively short and more consistent with a committee report rather than a full Annual Report (10-K) or standalone Audit Report (AR). It is not a certification or a brief announcement but a detailed committee report on audit committee activities and evaluations. This fits best under the category of Audit Report / Information (AR), which includes audit reports and related committee evaluations, excluding full annual reports. Therefore, the classification is AR with high confidence. FY 2024
2025-04-28 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.